Press Releases

Antibiotics Before Checkpoint Inhibitors Tied to Worse Survival

Novel Agents and Drug Development Needs in Advanced Clear Cell Renal Cancer

Toxicity, Clinical Outcomes of Varying Cabozantinib Dosage in Metastatic RCC

Sarcomatoid Renal Cell Carcinoma: Population-Based Study of 879 Patients

A five-gene signature predicts overall survival of patients with papillary renal cell carcinoma

Brian I. Rini, MD, on Renal Cell Carcinoma: Results From the TIVO-3 Trial on Tivozanib vs Sorafenib

Brian I. Rini, MD, on Renal Cell Cancer: Risk Stratification After Resection of Localized Disease

ASCO GU 2019: When to Obtain Genetic Testing for Syndromic Renal Cell Cancer

Top Medications Used to Treat Kidney (Renal Cell Cancer)

Dr. McDermott on Single-Agent Pembrolizumab in Advanced RCC

« Previous 1 … 4 5 6 7 8 9 Next »